IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today provided the following updates on earnings per share (EPS) and sales expectations based on current information.
Third Quarter 2014
Allergan expects non-GAAP diluted EPS attributable to stockholders for the third quarter of 2014 to be between $1.76 and $1.78, representing an increase of between 43 and 45 percent compared to non-GAAP diluted EPS attributable to stockholders for the third quarter of 2013. Previous guidance provided for non-GAAP diluted EPS attributable to stockholders for the third quarter of 2014 was between $1.44 and $1.47.
Help employers find you! Check out all the jobs and post your resume.
Third Quarter 2014
Allergan expects non-GAAP diluted EPS attributable to stockholders for the third quarter of 2014 to be between $1.76 and $1.78, representing an increase of between 43 and 45 percent compared to non-GAAP diluted EPS attributable to stockholders for the third quarter of 2013. Previous guidance provided for non-GAAP diluted EPS attributable to stockholders for the third quarter of 2014 was between $1.44 and $1.47.
Help employers find you! Check out all the jobs and post your resume.
